Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancreatic Adenocarcinoma × Resistance Training × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 26 Breast Neoplasms 20 Neoplasms 12 Prostatic Neoplasms 10 Obesity 6 Colorectal Neoplasms 6 Sarcopenia 5 Pancreatic Neoplasms 5 Head and Neck Neoplasms 5 Polycystic Ovary Syndrome 4 Lung Neoplasms 4 Multiple Myeloma 3 Lymphedema 3 Fatigue 3 Colonic Neoplasms 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Signs and Symptoms 2 Pharyngeal Neoplasms 2 Lymphoma 2 Leukemia 2 Laryngeal Neoplasms 2 Insulin Resistance 2 Inflammation 2 Diabetes Mellitus, Type 2 2 Cachexia 2 Weight Loss 1 Uterine Neoplasms 1 Urinary Incontinence 1 Urinary Bladder Neoplasms 1

Interventions

Gemcitabine 10 Albumin-Bound Paclitaxel 7 Taxes 5 130-nm albumin-bound paclitaxel 5 Fluorouracil 4 Radiotherapy, Intensity-Modulated 3 Oxaliplatin 3 dehydroftorafur 2 Radiotherapy 2 Leucovorin 2 Irinotecan 2 tocilizumab 1 selicrelumab 1 niraparib 1 irinotecan sucrosofate 1 indusatumab 1 folfirinox 1 durvalumab 1 cobimetinib 1 atezolizumab 1 Tiragolumab 1 Surgical Procedures, Operative 1 S 1 (combination) 1 Resistance Training 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Radiosurgery 1 Panitumumab 1 Pancreatectomy 1 PEGPH20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02680990 2018-02-28

REACT

Milton S. Hershey Medical Center

Phase NA Completed

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡